未登录

M

Marisa Stebegg

uk research & innovation (ukri)

H指数:7

被引数:741

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2023-07-1832

OA

Treatment with amlitelimab-a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody-reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2023-01-255

PRE

Amlitelimab reduces serum IL-13 in a phase 2a clinical trial in atopic dermatitis without impacting T-cell expansion in a T-cell recall assay

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2023-01-250

PRE

Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination

疫苗接种后恢复常规树突状细胞和T滤泡辅助细胞的形成

IF0

2020-03-2447

OA

Follicular Regulatory T Cells Can Access the Germinal Center Independently of CXCR5

IF6.9

2020-01-0144

OAAI

Heterochronic faecal transplantation boosts gut germinal centres in aged mice

异慢性粪便移植可增强老年小鼠的肠道生发中心

NATURE COMMUNICATIONS

IF15.7

2019-06-0479

OAAI

Regulation of the Germinal Center Response

生发中心反应的调节

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-10-25264

OAAI

Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation

IF6.9

2017-06-0163

OAAI